Literature DB >> 21381513

Improving antibiotic markets for long-term sustainability.

Aaron S Kesselheim1, Kevin Outterson.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21381513

Source DB:  PubMed          Journal:  Yale J Health Policy Law Ethics        ISSN： 1535-3532


× No keyword cloud information.
  9 in total

1.  The ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress.

Authors:  John K Billington
Journal:  Health Secur       Date:  2015-11-16

2.  Assessing Proposals for New Global Health Treaties: An Analytic Framework.

Authors:  Steven J Hoffman; John-Arne Røttingen; Julio Frenk
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

3.  Accelerating innovation in rapid diagnostics and targeted antibacterials.

Authors:  Thomas J Hwang; John H Powers; Daniel Carpenter; Aaron S Kesselheim
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

4.  An international legal framework to address antimicrobial resistance.

Authors:  Steven J Hoffman; Kevin Outterson; John-Arne Røttingen; Otto Cars; Charles Clift; Zain Rizvi; Fiona Rotberg; Göran Tomson; Anna Zorzet
Journal:  Bull World Health Organ       Date:  2015-02-01       Impact factor: 9.408

Review 5.  A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics.

Authors:  Matthew J Renwick; David M Brogan; Elias Mossialos
Journal:  J Antibiot (Tokyo)       Date:  2015-10-14       Impact factor: 2.649

Review 6.  Towards the just and sustainable use of antibiotics.

Authors:  Gemma L Buckland Merrett; Gerald Bloom; Annie Wilkinson; Hayley MacGregor
Journal:  J Pharm Policy Pract       Date:  2016-10-07

Review 7.  Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.

Authors:  Victoria L Simpkin; Matthew J Renwick; Ruth Kelly; Elias Mossialos
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

8.  Social, cultural and economic aspects of antimicrobial resistance.

Authors:  Timo Minssen; Kevin Outterson; Susan Rogers Van Katwyk; Pedro Henrique D Batista; Clare I R Chandler; Francesco Ciabuschi; Stephan Harbarth; Aaron S Kesselheim; Ramanan Laxminarayan; Kathleen Liddell; Michael T Osterholm; Lance Price; Steven J Hoffman
Journal:  Bull World Health Organ       Date:  2020-12-01       Impact factor: 9.408

Review 9.  Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus.

Authors:  Chantal M Morel; Olof Lindahl; Stephan Harbarth; Marlieke E A de Kraker; Suzanne Edwards; Aidan Hollis
Journal:  J Antibiot (Tokyo)       Date:  2020-03-19       Impact factor: 2.649
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.